Drug Profile
Research programme: Natural Killer receptor inhibitor - BioLineRx
Alternative Names: BL-9020; EDP 10; Natural cytotoxicity triggering receptor inhibitor - BioLineRx - BioLineRx; NKp46 inhibitor - BioLineRxLatest Information Update: 18 May 2021
Price :
$50
*
At a glance
- Originator Ben Gurion University; Hebrew University of Jerusalem
- Developer Ben Gurion University; BioLineRx; Hebrew University of Jerusalem
- Class Monoclonal antibodies
- Mechanism of Action Natural cytotoxicity triggering receptor 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 1 diabetes mellitus